|
Mutation Information
|
Mutation Site
|
M184I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
NRTIs |
|
Country
|
Uganda |
Literature Information
|
PubMed PMID
|
32475121
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
AIDS research and human retroviruses |
|
Title
|
High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda. |
|
Author
|
Segujja F,Omooja J,Lunkuse S,Nanyonjo M,Nabirye SE,Nassolo F,Bugembe DL,Bbosa N,Kateete DP,Ssenyonga W,Mayanja Y,Nsubuga RN,Seeley J,Kaleebu P,Ssemwanga D |
|
Evidence
|
The mutation K103N was detected in 62.5% (30/48) of participants, 41.7% (20/48) had M184V/I, 14.6% had K65R, and 12.5% (6/48) had thymidine analog mutations (TAMs).
|
|
|
HIV Mutation Detail Information